---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-24-000018"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2024-02-28T23:59:59+00:00"
generated_at: "2026-06-05T10:16:51.823545+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences CEO Jan De Witte to retire by end of 2024; Stuart Essig named Executive Chairman

## Summary
- Jan De Witte to retire as President and CEO by end of 2024 after successor appointed; will remain until transition.
- Stuart Essig, current Chairman, appointed Executive Chairman effective immediately to lead transition.
- Board engaged Heidrick & Struggles to search for new CEO candidate; expects to appoint successor by end of 2024.
- De Witte to serve as Senior Advisor from transition date through March 2026 under consulting agreement with base salary and bonus eligibility.
- De Witte's retirement is for personal reasons, not due to disagreement with company operations or policies.

## SEC filing metadata
- accession: 0000917520-24-000018
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2024-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/iart-20240227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-24-000018
- JSON: https://secwatch.observer/filing/0000917520-24-000018.json
- Plain text: https://secwatch.observer/filing/0000917520-24-000018.txt

## Key facts
- Executive change
  Stuart M. Essig was appointed as Executive Chairman at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: appointed
  - Role: Executive Chairman
  source text: On February 27, 2024, the Company’s Board of Directors appointed Stuart M. Essig, Ph.D., the Company’s Chairman, to the role of Executive Chairman, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm
- Executive change
  Jan De Witte departed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: retire
  - Role: President and Chief Executive Officer
  source text: On February 27, 2024, Jan De Witte informed Integra LifeSciences Holdings Corporation (the “Company”) of his intention to retire from his position as President and Chief Executive Officer and director of the Company following the completion of a succession process.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.